Evan Guggenheim - Emerging Cell & Gene Therapies

Release Date:

Evan Guggenheim, PhD is Executive Director & Head of Research Operations at Sana Biotechnology, a startup dedicated to developing stem cell therapies and methods for in vivo delivery of gene therapy components to treat a variety of diseases. Prior to joining Sana, Evan worked as a Scientist at a sequencing company called Intelligent Bio-Systems (acquired by Qiagen in 2012) as well as at the large biotechnology company Biogen, where he rose through the ranks from the position of Scientist to ultimately become the Director of R&D Strategy and Portfolio Leadership. In this episode, we discuss ways that you can ‘de-risk yourself’ when you’re first entering the job market and how you can climb the corporate ladder at a large biotech/pharma company. We also talk about how your role as an employee, long-term job stability, and work-life balance can vary based on your particular work environment. Furthermore, we discuss the current state of cell & gene therapies and pinpoint key growth opportunities.Hosted by Roshan Chikarmane and Jenna Glatzer. 

Evan Guggenheim - Emerging Cell & Gene Therapies

Title
Evan Guggenheim - Emerging Cell & Gene Therapies
Copyright
Release Date

flashback